Skip to main content
Corinne Linardic, MD, Pediatric Hematology & Oncology, Durham, NC

Corinne M Linardic MD

Pediatric Coagulation Disorder Hematology


Associate Professor, Pediatrics, Duke University School of Medicine

Join to View Full Profile
  • 2100 Erwin RdDurham, NC 27705

  • Phone+1 919-620-4467

Dr. Linardic is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Pediatric Hematology/Oncology, 1999 - 2001
  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 1998 - 1999
  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaResidency, Pediatrics, 1995 - 1998
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1995

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1999 - 2025
  • PA State Medical License
    PA State Medical License 1996 - 2000
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Journal Articles

  • Soft Tissue Sarcoma Cancer Stem Cells: An Overview  
    Corinne M Linardic, Katia C Genadry, Frontiers in Neurology
  • Proceedings of the Fifth International RASopathies Symposium: When Development and Cancer Intersect  
    David A Stevenson, Katherine A Rauen, Bruce D Gelb, Corinne M Linardic, Suma Shankar, Brigitte C Widemann, Karen Gripp, Maxim Itkin, American Journal of Medical Genetics Part A

Press Mentions

  • Precision Genomics Collaboratory Graduate Student Pilot Grants Announced
    Precision Genomics Collaboratory Graduate Student Pilot Grants AnnouncedAugust 3rd, 2021

Grant Support

  • Chemical Approaches to Modulate PAX3-FOXO1 in Fusion-Positive Alveolar RhabdomyosarcomaMASSACHUSETTS INSTITUTE OF TECHNOLOGY2024–2029
  • Duke Center for Advancement of Child Health (CAtCH)DUKE UNIVERSITY2021–2026
  • Proteasomal recruiters of PAX3-FOXO1 Designed via Sequence-Based Generative ModelsDUKE UNIVERSITY2023–2025
  • Proteasomal recruiters of PAX3-FOXO1 Designed via Sequence-Based Generative ModelsDUKE UNIVERSITY2023–2025
  • Proteasomal recruiters of PAX3-FOXO1 Designed via Sequence-Based Generative ModelsDUKE UNIVERSITY2023–2025
  • Defining and targeting the molecular vulnerabilities of the PAX3-FOXO1 protein in rhabdomyosarcomaDUKE UNIVERSITY2020–2025
  • Defining and targeting the molecular vulnerabilities of the PAX3-FOXO1 protein in rhabdomyosarcomaDUKE UNIVERSITY2020–2025
  • Defining and targeting the molecular vulnerabilities of the PAX3-FOXO1 protein in rhabdomyosarcomaDUKE UNIVERSITY2020–2025
  • Defining and targeting the molecular vulnerabilities of the PAX3-FOXO1 protein in rhabdomyosarcomaDUKE UNIVERSITY2019–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: